Cargando…
Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience
BACKGROUND: We retrospectively reviewed data from nine pre-treated metastatic desmoplastic small round cell tumour (DSRCT) patients who received pazopanib. PATIENTS AND METHODS: Three patients received pazopanib within the EORTC phase II 62043, three in the EORTC phase III 62072, and three in the co...
Autores principales: | Frezza, Anna Maria, Benson, Charlotte, Judson, Ian R, Litiere, Saskia, Marreaud, Sandrine, Sleijfer, Stefan, Blay, Jean-Yves, Dewji, Raz, Fisher, Cyril, van der Graaf, Winette, Hayward, Larry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4118147/ https://www.ncbi.nlm.nih.gov/pubmed/25089183 http://dx.doi.org/10.1186/2045-3329-4-7 |
Ejemplares similares
-
Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor
por: Menegaz, Brian A., et al.
Publicado: (2017) -
Prognostic Significance of Bone Metastasis in Soft Tissue Sarcoma Patients Receiving Palliative Systemic Therapy: An Explorative, Retrospective Pooled Analysis of the EORTC-Soft Tissue and Bone Sarcoma Group (STBSG) Database
por: Kantidakis, Georgios, et al.
Publicado: (2022) -
Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature
por: Wong, Han Hsi, et al.
Publicado: (2013) -
Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer‐Soft Tissue and Bone Sarcoma Group (EORTC‐STBSG)
por: Lindner, Lars H., et al.
Publicado: (2018) -
Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study
por: Sleijfer, S, et al.
Publicado: (2012)